Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

Emerging Temporal Lobe Dysfunction in People at Clinical High Risk for Psychosis.

Allen P, Moore H, Corcoran CM, Gilleen J, Kozhuharova P, Reichenberg A, Malaspina D.

Front Psychiatry. 2019 May 13;10:298. doi: 10.3389/fpsyt.2019.00298. eCollection 2019. Review.

2.

An experimental medicine study of the phosphodiesterase-4 inhibitor, roflumilast, on working memory-related brain activity and episodic memory in schizophrenia patients.

Gilleen J, Farah Y, Davison C, Kerins S, Valdearenas L, Uz T, Lahu G, Tsai M, Ogrinc F, Reichenberg A, Williams SC, Mehta MA, Shergill SS.

Psychopharmacology (Berl). 2018 Dec 8. doi: 10.1007/s00213-018-5134-y. [Epub ahead of print]

PMID:
30536081
3.

MDMA Increases Cooperation and Recruitment of Social Brain Areas When Playing Trustworthy Players in an Iterated Prisoner's Dilemma.

Gabay AS, Kempton MJ, Gilleen J, Mehta MA.

J Neurosci. 2019 Jan 9;39(2):307-320. doi: 10.1523/JNEUROSCI.1276-18.2018. Epub 2018 Nov 19.

4.

Attractor-like Dynamics in Belief Updating in Schizophrenia.

Adams RA, Napier G, Roiser JP, Mathys C, Gilleen J.

J Neurosci. 2018 Oct 31;38(44):9471-9485. doi: 10.1523/JNEUROSCI.3163-17.2018. Epub 2018 Sep 5.

5.

Peripheral oxytocin and vasopressin: Biomarkers of psychiatric disorders? A comprehensive systematic review and preliminary meta-analysis.

Rutigliano G, Rocchetti M, Paloyelis Y, Gilleen J, Sardella A, Cappucciati M, Palombini E, Dell'Osso L, Caverzasi E, Politi P, McGuire P, Fusar-Poli P.

Psychiatry Res. 2016 Jul 30;241:207-20. doi: 10.1016/j.psychres.2016.04.117. Epub 2016 May 5. Review.

6.

Self-reflection and set-shifting mediate awareness in cognitively preserved schizophrenia patients.

Gilleen J, David A, Greenwood K.

Cogn Neuropsychiatry. 2016 May;21(3):185-96. doi: 10.1080/13546805.2016.1167031. Epub 2016 Apr 26.

PMID:
27112316
7.

The relationship between cognitive insight and depression in psychosis and schizophrenia: a review and meta-analysis.

Palmer EC, Gilleen J, David AS.

Schizophr Res. 2015 Aug;166(1-3):261-8. doi: 10.1016/j.schres.2015.05.032. Epub 2015 Jun 19. Review.

PMID:
26095015
8.

Modafinil combined with cognitive training: pharmacological augmentation of cognitive training in schizophrenia.

Michalopoulou PG, Lewis SW, Drake RJ, Reichenberg A, Emsley R, Kalpakidou AK, Lees J, Bobin T, Gilleen JK, Pandina G, Applegate E, Wykes T, Kapur S.

Eur Neuropsychopharmacol. 2015 Aug;25(8):1178-89. doi: 10.1016/j.euroneuro.2015.03.009. Epub 2015 Mar 31.

PMID:
25921551
9.

Impaired subjective well-being in schizophrenia is associated with reduced anterior cingulate activity during reward processing.

Gilleen J, Shergill SS, Kapur S.

Psychol Med. 2015 Feb;45(3):589-600. doi: 10.1017/S0033291714001718. Epub 2014 Jul 30.

PMID:
25075776
10.

Modafinil combined with cognitive training is associated with improved learning in healthy volunteers--a randomised controlled trial.

Gilleen J, Michalopoulou PG, Reichenberg A, Drake R, Wykes T, Lewis SW, Kapur S.

Eur Neuropsychopharmacol. 2014 Apr;24(4):529-39. doi: 10.1016/j.euroneuro.2014.01.001. Epub 2014 Jan 16.

PMID:
24485800
11.

The role of memory in awareness of memory deficits in Alzheimer's disease, schizophrenia, and brain injury.

Gilleen J, Greenwood K, David AS.

J Clin Exp Neuropsychol. 2014;36(1):43-57. doi: 10.1080/13803395.2013.863835. Epub 2013 Dec 17.

PMID:
24344744
12.

Dysregulated but not decreased salience network activity in schizophrenia.

White TP, Gilleen J, Shergill SS.

Front Hum Neurosci. 2013 Mar 7;7:65. doi: 10.3389/fnhum.2013.00065. eCollection 2013.

13.

Exploring psychotic symptoms: a comparison of motor related neuronal activation during and after acute psychosis.

Rains LS, Fallica G, O'Daly O, Gilleen J, Giampetro V, Morley L, Shergill S.

BMC Psychiatry. 2012 Aug 7;12:102. doi: 10.1186/1471-244X-12-102.

14.

Failures of metacognition and lack of insight in neuropsychiatric disorders.

David AS, Bedford N, Wiffen B, Gilleen J.

Philos Trans R Soc Lond B Biol Sci. 2012 May 19;367(1594):1379-90. doi: 10.1098/rstb.2012.0002.

15.

The role of premorbid personality and cognitive factors in awareness of illness, memory, and behavioural functioning in Alzheimer's disease.

Gilleen J, Greenwood K, Archer N, Lovestone S, David AS.

Cogn Neuropsychiatry. 2012 May;17(3):227-45. doi: 10.1080/13546805.2011.588007. Epub 2011 Sep 19.

PMID:
21929281
16.

Increased use of antipsychotic long-acting injections with community treatment orders.

Patel MX, Matonhodze J, Baig MK, Gilleen J, Boydell J, Holloway F, Taylor D, Szmukler G, Lambert T, David AS.

Ther Adv Psychopharmacol. 2011 Apr;1(2):37-45. doi: 10.1177/2045125311407960.

17.

Premorbid personality and insight in first-episode psychosis.

Campos MS, Garcia-Jalon E, Gilleen JK, David AS, Peralta VM, Cuesta MJ.

Schizophr Bull. 2011 Jan;37(1):52-60. doi: 10.1093/schbul/sbq119. Epub 2010 Oct 25.

18.

Domains of awareness in schizophrenia.

Gilleen J, Greenwood K, David AS.

Schizophr Bull. 2011 Jan;37(1):61-72. doi: 10.1093/schbul/sbq100. Epub 2010 Sep 17.

19.

Functional magnetic resonance imaging of inner speech in schizophrenia.

Simons CJ, Tracy DK, Sanghera KK, O'Daly O, Gilleen J, Dominguez MD, Krabbendam L, Shergill SS.

Biol Psychiatry. 2010 Feb 1;67(3):232-7. doi: 10.1016/j.biopsych.2009.09.007. Epub 2009 Oct 20.

PMID:
19846064
20.

The cognitive neuropsychiatry of delusions: from psychopathology to neuropsychology and back again.

Gilleen J, David AS.

Psychol Med. 2005 Jan;35(1):5-12. Review.

PMID:
15842024

Supplemental Content

Loading ...
Support Center